Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article

This article is part of the supplement: The Third International Symposium on the Molecular Biology of Breast Cancer

Email this article to a friend

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

MK Schmidt, TC van Sprundel, MA Rookus, R Brohet, CJ van Asperen, EJTh Rutgers, RAEM Tollenaar and LJ van 't Veer

Breast Cancer Research 2005, 7(Suppl 2):P1.09 doi:10.1186/bcr1096

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.